Interpace Diagnostics Corporation
10Patents
10Active
10Granted
49Portfolio score
Filing activity: Nov 17, 2011 → Feb 26, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9341628B2 | Methods for measuring carcinoembryonic antigen | Physics | 1 | Active |
| US9644241B2 | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease | Chemistry; Metallurgy | 1 | Active |
| US12205676B2 | Methods for treating Barrett's metaplasia and esophageal adenocarcinoma | Human Necessities | 0 | Active |
| US10131942B2 | Methods for treating barrett's metaplasia and esophageal adenocarcinoma | Human Necessities | 0 | Active |
| US10444239B2 | Methods for measuring carcinoembryonic antigen | Physics | 0 | Active |
| US10255410B2 | Methods for treating Barrett's metaplasia and esophageal adenocarcinoma | Human Necessities | 0 | Active |
| US11143657B2 | Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11118231B2 | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms | Chemistry; Metallurgy | 0 | Active |
| US10655184B2 | Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease | Chemistry; Metallurgy | 0 | Active |
| US10150999B2 | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.